Duration of Prophylactic Levetiracetam After Surgery for Brain Tumor: A Prospective Randomized Trial
Maryam Rahman(University of Florida), Jean E. Cibula(University of Florida), Nina McGrew(University of Florida), Jessica Smith(University of Florida), Ashley Ghiaseddin(University of Florida), Shelley C. Heaton(University of Florida Health), Greg J A Murad(University of Florida), Yu Wang(University of Florida Health), Marcia Hodik(University of Florida), Kaitlyn Melnick(UF Health Shands Hospital), Stephan Eisenschenk(University of Florida), Steven Roper(University of Florida)
Cited by 12
Related Papers
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
|Current Treatment Options in Oncology|2020|101
Enhanced recovery after surgery (ERAS) for open transforaminal lumbar interbody fusion: a retrospective propensity-matched cohort study
|The Spine Journal|2021|51
Contemporary RNA Therapeutics for Glioblastoma
|NeuroMolecular Medicine|2021|45
Enhanced recovery after surgery (ERAS) improves return of physiological function in frail patients undergoing one- to two-level TLIFs: an observational retrospective cohort study
|The Spine Journal|2022|42
Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer
|Prostate Cancer and Prostatic Diseases|2014|37